Evidence map›Paper›PMID 29721854›Full record

ArticleMolecular neurobiology2019

Abscisic Acid Supplementation Rescues High Fat Diet-Induced Alterations in Hippocampal Inflammation and IRSs Expression.

Alberto Ribes-Navarro, Mariam Atef, Sandra Sánchez-Sarasúa, María Teresa Beltrán-Bretones, Francisco Olucha-Bordonau, Ana María Sánchez-Pérez

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Can We Treat Neuroinflammation in Alzheimer's Disease?International journal of molecular sciences · 2020
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alberto Ribes-NavarroDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain.
Mariam AtefDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain.
Sandra Sánchez-SarasúaDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain.
María Teresa Beltrán-BretonesDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain.
Francisco Olucha-BordonauDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain.
Ana María Sánchez-PérezDepartment of Medicine, University of Jaume I, Castellón de la Plana, Spain. sanchean@uji.es.
Universitat Jaume I · ES

Funding

Generalitat Valenciana AICO/2015/042
6 · The paper itself

Abstract

Accumulated evidence indicates that neuroinflammation induces insulin resistance in the brain. Moreover, both processes are intimately linked to neurodegenerative disorders, including Alzheimer's disease. Potential mechanisms underlying insulin resistance include serine phosphorylation of the insulin receptor substrate (IRS) or insulin receptor (IR) misallocation. However, only a few studies have focused on IRS expression in the brain and its modulation in neuroinflammatory processes. This study used the high-fat diet (HFD) model of neuroinflammation to study the alterations of IR, an insulin-like growth factor receptor (IGF1R) and IRS expressions in the hippocampus. We observed that HFD effectively reduced mRNA and protein IRS2 expression. In contrast, a HFD induced the upregulation of the IRS1 mRNA levels, but did not alter an IR and IGF1R expression. As expected, we observed that a HFD increased hippocampal tumor necrosis factor alpha (TNFα) and amyloid precursor protein (APP) levels while reducing brain-derived neurotrophic factor (BDNF) expression and neurogenesis. Interestingly, we found that TNFα correlated positively with IRS1 and negatively with IRS2, whereas APP levels correlated positively only with IRS1 but not IRS2. These results indicate that IRS1 and IRS2 hippocampal expression can be affected differently by HFD-induced neuroinflammation. In addition, we aimed to establish whether abscisic acid (ABA) can rescue hippocampal IRS1 and IRS2 expression, as we had previously shown that ABA supplementation prevents memory impairments and improves neuroinflammation induced by a HFD. In this study, ABA restored HFD-induced hippocampal alterations, including IRS1 and IRS2 expression, TNFα, APP, and BDNF levels and neurogenesis. In conclusion, this study highlights different regulations of hippocampal IRS1 and IRS2 expression using a HFD, indicating the important differences of these scaffolding proteins, and strongly supports ABA therapeutic effects.

Indexed as

Abscisic AcidAmyloid beta-Protein PrecursorAnimalsBiomarkersBrain-Derived Neurotrophic FactorDiet, High-FatGene Expression RegulationHippocampusInflammationInsulin Receptor Substrate ProteinsMaleNeurogenesisRats, WistarRNA, MessengerTumor Necrosis Factor-alphaWeight GainAbscisic AcidAmyloid beta-Protein PrecursorBiomarkersBrain-Derived Neurotrophic FactorInsulin Receptor Substrate ProteinsRNA, MessengerTumor Necrosis Factor-alphaAPPBDNFHippocampusInsulin resistanceNeurogenesisNeuroinflammation

Identifiers

PMID29721854
OpenAlexW2801666555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.